Hair Growth Treatment
TrichoSeeds Co., a biotech founded by Junji Fukuda PhD, has announced a timeline for the start of its hair cloning clinical trial. Note, the snippet above taken from the ko-karie.com website has been edited since the publishing of this article. Luckily, we caught a screenshot of it before the change was made. The…
Read More
Epibiotech EPI-001 Approval by the Ministry of Food and Drug Safety Update (12/21/2023) As of December 21st, 2023, Epibiotech has been approved by the Ministry of Food and Drug Safety to start Phase 1/2a clinical trials for its EPI-001 autologous dermal papilla cell treatment to treat androgenetic alopecia. Safety will be measured in Phase 1…
Read More
China Trial Enrolls 180 Patients To Complete Enrollment: Update (8/22/23) On August 22, 2023, Kintor Pharmaceutical announced the completion of patient enrollment in a phase 2 trial in China for GT20029. This means all of the patients needed to complete the study have been enrolled, and will undergo their dosing schedule over the next 12…
Read More
Seeking Scarless Hair Transplants With Donor Regeneration On July 11th, 2023, Dr. Blake Bloxham completed a verteporfin trial in his New York office. The trial focused on testing verteporfin’s effect on minimizing scarring or potentially producing scarless healing during a hair transplant procedure. Dr. Bloxham treated three different patients undergoing FUT (Follicular Unit Transplantation) hair…
Read More
Carmell Therapeutics Merger Finalization Update (09/12/2023) As of September 12th, 2023, Carmell Therapeutics has finalized a merger with a regenerative medicine company called Axolotl Biologix. The company names it a “significant development for the future of regenerative medicine”. Axolotl Biologix is a company that conducts research in regenerative medicines to design and develop human amniotic…
Read More
Life Code shares poster from the 25th World Congress of Dermatology Singapore 2023 with Follicle Thought. Artificial Intelligence Small Molecule Enhanced Hair Growth Follicle Thought is pleased to share an exclusive look at Life Code’s poster from the current World Congress of Dermatology event. Just over a year ago, I shared an introduction to Life…
Read More
Things are really heating up in the hair loss treatment industry on the first day of Summer 2023. Let’s take a look at all pertinent information and happenings in the AGA clinical trial world below. Cosmo Pharma Lists Phase 3 Trial On ClinicalTrials.gov A trial which was once highly anticipated, then questioned if it would…
Read More
Follicle Thought is pleased to announce a new company developing a treatment for androgenetic alopecia with an innovative technology. Unlike most other biotechs tackling the challenging field of hair regeneration, StimuSIL is a biomedical device company. Their team has created a completely new way to deliver photobiomodulation and incorporated it into a proprietary, patented hair…
Read More
A company working in protein degradation has entered the field of hair loss therapeutics in Spring 2023 with a new anti-hair loss drug. AH-001 AnHorn Medicines As I’ve stated before, we are in a new era for hair loss medication. Whereas in years past we would see a new therapy or company emerge once per…
Read More
An Indian drug-discovery startup with a focus on dermatology has unveiled its new website. Inovaugmet Research, which was mentioned in a recent article on Follicle Thought, is aiming to bring new therapies to unmet dermatological needs. Inovaugmet utilizes a dermatology-specific drug discovery platform called iNeu-3D screen to find new molecules. From the company’s website, iNeu-3D…
Read More